Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
LB.1.7.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.9NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.25 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.25.1 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.25.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.75 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.100 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.44 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LD.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KW.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.15.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.50.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LB.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LF.3.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDK.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.4.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.26NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.37NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JQ.2.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.23.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DY.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
KP.2.4NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LJ.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LE.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MD.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.1.16NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LE.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDQNChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.502NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.285NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.582NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.580NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.306NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.280NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.329NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-18512.9China
B.1.396NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.595.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.2NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.311NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.369NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.367NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.595NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.240NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DL.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used